Page 4 - பகுப்பாய்வு வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RTW Leads $106 Million Financing Round in Tenaya Therapeutics RTW Venture Fund Limited (the Company ), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Tenaya Therapeutics, Inc. ( Tenaya ) on 01 March 2021 of its completion of a $106 million Series C financing round led by RTW Investments, LP (the Investment Manager ). The Company, alongside other investment vehicles of the Investment Manager, confirms that it participated in the financing round together with other investment firms. Tenaya is a US-based privately held biotechnology company with a mission to discover, develop, and deliver curative therapies that address the underlying causes of heart disease. Tenaya is developing three platforms to address heart disease: Gene Therapy, Regeneration, and Precision Medicine. The proceeds from the financing round will be used to adv

City ofUnited kingdomFaraz aliAlexandra taracanovaWendy ryanBroderick wongCharles rylandEric olsonJulia enrightHenry wilsonStephanie sirotaGeorge bealeVenture fund limited the companyVenture fundGood laboratory practiceTenaya therapeutics inc